US5417671A
(en)
*
|
1990-05-23 |
1995-05-23 |
Jackson; Richard R. |
Medical devices having local anesthetic effect and methods of their manufacture
|
EP0787201B1
(de)
*
|
1995-08-17 |
2004-04-28 |
Crucell Holland B.V. |
Poly(organo)phosphazene in synthetischen transfektions-systemen
|
DE19545257A1
(de)
|
1995-11-24 |
1997-06-19 |
Schering Ag |
Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
|
DE19611769A1
(de)
*
|
1996-03-14 |
1997-09-18 |
Schering Ag |
Mikropartikel, Verfahren zu deren Herstellung, sowie deren Verwendung in der Ultraschall Diagnostik
|
WO1998004743A1
(en)
*
|
1996-07-29 |
1998-02-05 |
The Regents Of The University Of California |
Polymeric assemblies for sensitive colorimetric assays
|
US5980972A
(en)
*
|
1996-12-20 |
1999-11-09 |
Schneider (Usa) Inc |
Method of applying drug-release coatings
|
US5958414A
(en)
*
|
1997-09-03 |
1999-09-28 |
Heska Corporation |
Composition to protect a mammal against Bartonella henselae infection
|
US6485514B1
(en)
*
|
1997-12-12 |
2002-11-26 |
Supergen, Inc. |
Local delivery of therapeutic agents
|
US6986902B1
(en)
*
|
1998-04-28 |
2006-01-17 |
Inex Pharmaceuticals Corporation |
Polyanionic polymers which enhance fusogenicity
|
KR100395320B1
(ko)
*
|
1998-08-19 |
2003-12-24 |
주식회사 원진신약 |
공기분사법에의해제조되는미세분말및그의제조방법
|
US20050153926A1
(en)
*
|
1998-12-04 |
2005-07-14 |
Adams Christopher P. |
Method for the immobilization of oligonucleotides
|
US20040234472A1
(en)
|
2001-04-20 |
2004-11-25 |
Jackson John K. |
Micellar drug delivery systems for hydrophobic drugs
|
DE10011564C1
(de)
*
|
2000-03-09 |
2001-09-27 |
Goldschmidt Ag Th |
Verfahren zur Herstellung von Polyorganosiloxanemulsionen
|
DK1272213T3
(da)
|
2000-04-06 |
2006-07-10 |
Seer Pharmaceuticals Llc |
Mikrobielt afgivelsessystem
|
AU2002235253A8
(en)
|
2000-12-21 |
2005-10-06 |
Inhale Therapeutic Syst |
Induced phase transition method for the production of microparticles containing hydrophilic active agents
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US9080146B2
(en)
*
|
2001-01-11 |
2015-07-14 |
Celonova Biosciences, Inc. |
Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
AU2002337692B2
(en)
|
2001-09-26 |
2007-09-13 |
Baxter International Inc. |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
US20080226723A1
(en)
*
|
2002-07-05 |
2008-09-18 |
Celonova Biosciences, Inc. |
Loadable Polymeric Particles for Therapeutic Use in Erectile Dysfunction and Methods of Preparing and Using the Same
|
AU2003266525A1
(en)
*
|
2002-09-18 |
2004-04-08 |
Koyama, Yuu |
Process for producing microcapsule
|
US20040058008A1
(en)
*
|
2002-09-20 |
2004-03-25 |
Tarcha Peter J. |
Microparticles having serum as a dispersing agent and process for their preparation and use
|
US20040131631A1
(en)
*
|
2002-11-22 |
2004-07-08 |
Alexander Andrianov |
Polyphosphazene immunostimulants
|
TWI350762B
(en)
*
|
2004-02-12 |
2011-10-21 |
Euro Celtique Sa |
Particulates
|
WO2005079856A1
(en)
*
|
2004-02-23 |
2005-09-01 |
The University Of British Columbia |
Drug delivery compositions comprising hydrophobic polymers and amphipathic molecules
|
US9498563B2
(en)
*
|
2004-04-23 |
2016-11-22 |
Boston Scientific Scimed, Inc. |
Medical articles having therapeutic-agent-containing regions formed from coalesced polymer particles
|
US8119153B2
(en)
|
2004-08-26 |
2012-02-21 |
Boston Scientific Scimed, Inc. |
Stents with drug eluting coatings
|
US20210299056A9
(en)
|
2004-10-25 |
2021-09-30 |
Varian Medical Systems, Inc. |
Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
|
US9114162B2
(en)
|
2004-10-25 |
2015-08-25 |
Celonova Biosciences, Inc. |
Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
|
US9107850B2
(en)
*
|
2004-10-25 |
2015-08-18 |
Celonova Biosciences, Inc. |
Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
|
BRPI0518383A2
(pt)
|
2004-10-25 |
2008-11-18 |
Polyzenix Gmbh |
partÍculas polimÉricas carregÁveis para aplicaÇÕes terepÊuticas e/ou diagnàstico e mÉtodos para preparar e usar as mesmas
|
WO2007001448A2
(en)
*
|
2004-11-04 |
2007-01-04 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US20060193820A1
(en)
|
2005-02-18 |
2006-08-31 |
Andrianov Alexander K |
Immunostimulating polyphosphazene compounds
|
WO2007070682A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
US20070254012A1
(en)
*
|
2006-04-28 |
2007-11-01 |
Ludwig Florian N |
Controlled degradation and drug release in stents
|
EP2019691B1
(de)
|
2006-05-15 |
2020-08-12 |
Massachusetts Institute of Technology |
Polymere für funktionelle partikel
|
WO2007137117A2
(en)
*
|
2006-05-17 |
2007-11-29 |
Massachusetts Institute Of Technology |
Aptamer-directed drug delivery
|
FR2902007B1
(fr)
*
|
2006-06-09 |
2012-01-13 |
Flamel Tech Sa |
Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s) ainsi que leurs applications notamment therapeutiques
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
US10669383B2
(en)
*
|
2006-10-31 |
2020-06-02 |
Evonik Corporation |
Spheronized polymer particles
|
EP2089029B1
(de)
|
2006-11-10 |
2012-10-03 |
Massachusetts Institute of Technology |
Pak inhibitoren zur behandlung von neurologischen entwicklungsstoerungen
|
WO2008147456A2
(en)
*
|
2006-11-20 |
2008-12-04 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
US9217129B2
(en)
*
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
EP2144600A4
(de)
|
2007-04-04 |
2011-03-16 |
Massachusetts Inst Technology |
Poly (aminsäure)-zielmoleküle
|
US20080292663A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Gerber Jay D |
Adjuvant compositions and methods for delivering vaccines
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
BRPI0817664A2
(pt)
|
2007-10-12 |
2015-03-24 |
Massachusetts Inst Technology |
Nanopartículas, método para preparar nanopartículas e método para tratar terapeuticamente ou profilaticamente um indivíduo
|
US20090110738A1
(en)
*
|
2007-10-26 |
2009-04-30 |
Celonova Biosciences, Inc. |
Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same
|
US20090111763A1
(en)
*
|
2007-10-26 |
2009-04-30 |
Celonova Biosciences, Inc. |
Loadable polymeric particles for bone augmentation and methods of preparing and using the same
|
US20090110730A1
(en)
*
|
2007-10-30 |
2009-04-30 |
Celonova Biosciences, Inc. |
Loadable Polymeric Particles for Marking or Masking Individuals and Methods of Preparing and Using the Same
|
US20090110731A1
(en)
*
|
2007-10-30 |
2009-04-30 |
Celonova Biosciences, Inc. |
Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same
|
WO2010009291A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles containing bioactive peptides
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8277812B2
(en)
*
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
NZ601345A
(en)
|
2008-10-16 |
2014-05-30 |
Univ Dalhousie |
Combination adjuvant formulation
|
ES2890501T3
(es)
|
2009-03-02 |
2022-01-20 |
Massachusetts Inst Technology |
Métodos y productos para la creación de perfiles enzimáticos in vivo
|
WO2010114770A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
MX2011010390A
(es)
*
|
2009-03-30 |
2011-12-14 |
Cerulean Pharma Inc |
Conjugados, particulas, composiciones de agentes polimericos y metodos relacionados de uso.
|
WO2010114768A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
CN102686244A
(zh)
*
|
2009-04-21 |
2012-09-19 |
西莱克塔生物科技公司 |
提供一种Th1-偏向性应答的免疫纳米疗法
|
MX2011012597A
(es)
|
2009-05-27 |
2012-04-19 |
Selecta Biosciences Inc |
Nanoportadores que poseen componentes con diferentes tasas de liberacion.
|
US9278998B2
(en)
|
2009-07-02 |
2016-03-08 |
Massachusetts Institute Of Technology |
Compositions and methods for diagnosing and/or treating influenza infection
|
IN2012DN00781A
(de)
|
2009-08-12 |
2015-06-26 |
Sigmoid Pharma Ltd |
|
ES2625406T3
(es)
|
2010-03-25 |
2017-07-19 |
Oregon Health & Science University |
Glicoproteínas de CMV y vectores recombinantes
|
CN107080839A
(zh)
|
2010-05-26 |
2017-08-22 |
西莱克塔生物科技公司 |
多价的合成纳米载体疫苗
|
ES2656971T3
(es)
|
2010-09-10 |
2018-03-01 |
Biosceptre (Aust) Pty Ltd |
Tratamientos para el cáncer en animales de compañía con un anticuerpo anti P2X7
|
US8802110B2
(en)
|
2010-09-21 |
2014-08-12 |
Massachusetts Institute Of Technology |
Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
|
AU2011312178B2
(en)
|
2010-10-04 |
2016-05-12 |
Massachusetts Institute Of Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
JP6245990B2
(ja)
|
2011-03-15 |
2017-12-13 |
マサチューセッツ インスティテュート オブ テクノロジー |
同位体によりコード化されたレポーターによる多重検出
|
SI2691530T1
(en)
|
2011-06-10 |
2018-08-31 |
Oregon Health & Science University |
CMV glycoproteins and recombinant vectors
|
EP2726095B1
(de)
|
2011-07-01 |
2018-06-06 |
Biosceptre (Aust) Pty Ltd |
Kombinationstherapie
|
CN103702687A
(zh)
|
2011-07-29 |
2014-04-02 |
西莱克塔生物科技公司 |
产生体液和细胞毒性t淋巴细胞(ctl)免疫应答的合成纳米载体
|
US20130189754A1
(en)
|
2011-09-12 |
2013-07-25 |
International Aids Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
|
US9402894B2
(en)
|
2011-10-27 |
2016-08-02 |
International Aids Vaccine Initiative |
Viral particles derived from an enveloped virus
|
BR122019027913B1
(pt)
|
2011-11-11 |
2021-11-30 |
Variation Biotechnologies, Inc |
Partícula vírus-like, composição farmacêutica compreendendo a referida partícula e método para produção da mesma
|
EP4218808A3
(de)
|
2012-03-12 |
2023-08-09 |
Advanced BioAdjuvants, LLC |
Adjuvans- und impfstoffzusammensetzungen
|
CA2871160C
(en)
|
2012-05-10 |
2023-03-14 |
Massachusetts Institute Of Technology |
Agents for influenza neutralization
|
EP3937179A1
(de)
|
2012-05-21 |
2022-01-12 |
Distributed Bio Inc |
Epitopfokussierung durch variable effektive antigenoberflächenkonzentration
|
EP2679596B1
(de)
|
2012-06-27 |
2017-04-12 |
International Aids Vaccine Initiative |
HIV-1 Env-proteinvariante
|
EP2882453B1
(de)
|
2012-08-07 |
2021-01-06 |
Massachusetts Institute of Technology |
Antikörper gegen das denguevirus und verwendungen davon
|
ES2959258T3
(es)
|
2013-02-07 |
2024-02-22 |
Childrens Medical Center |
Antígenos proteicos que proporcionan protección contra la colonización y/o la enfermedad neumocócicas
|
WO2014197723A2
(en)
|
2013-06-05 |
2014-12-11 |
Massachusetts Institute Of Technology |
Human adaptation of h7 ha
|
JP6847660B2
(ja)
|
2013-06-07 |
2021-03-24 |
マサチューセッツ インスティテュート オブ テクノロジー |
リガンドをコードする合成バイオマーカーのアフィニティベースの検出
|
EP2848937A1
(de)
|
2013-09-05 |
2015-03-18 |
International Aids Vaccine Initiative |
Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
|
US10058604B2
(en)
|
2013-10-07 |
2018-08-28 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
JP6707455B2
(ja)
|
2014-02-11 |
2020-06-10 |
マサチューセッツ インスティテュート オブ テクノロジー |
新規フルスペクトル抗デング抗体
|
CN104086724A
(zh)
*
|
2014-07-08 |
2014-10-08 |
成都市绿科华通科技有限公司 |
新型六方孔医用生物材料
|
US10010607B2
(en)
|
2014-09-16 |
2018-07-03 |
Institut Curie |
Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune response
|
US10174292B2
(en)
|
2015-03-20 |
2019-01-08 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
US9931394B2
(en)
|
2015-03-23 |
2018-04-03 |
International Aids Vaccine Initiative |
Soluble HIV-1 envelope glycoprotein trimers
|
CA3016860A1
(en)
*
|
2016-03-07 |
2017-09-14 |
Glaxosmithkline Biologicals Sa |
Drug delivery particles
|
JP6724156B2
(ja)
|
2016-03-16 |
2020-07-15 |
アンスティテュ・クリー |
環状ジヌクレオチドを含むウイルス粒子を調製する方法及びがんを治療するための前記粒子の使用
|
CA3020324A1
(en)
|
2016-04-08 |
2017-10-12 |
Massachusetts Institute Of Technology |
Methods to specifically profile protease activity at lymph nodes
|
WO2017193070A1
(en)
|
2016-05-05 |
2017-11-09 |
Massachusetts Institute Of Technology |
Methods and uses for remotely triggered protease activity measurements
|
US9833505B1
(en)
|
2016-07-18 |
2017-12-05 |
Variation Biotechnologies Inc. |
Vaccine compositions for treatment of Zika virus
|
AU2017300392B2
(en)
*
|
2016-07-18 |
2022-06-16 |
Tissuegen, Inc. |
Methods and compositions for maintaining the conformation and structural integrity of biomolecules
|
US11519905B2
(en)
|
2017-04-07 |
2022-12-06 |
Massachusetts Institute Of Technology |
Methods to spatially profile protease activity in tissue and sections
|
US11054428B2
(en)
|
2018-03-05 |
2021-07-06 |
Massachusetts Institute Of Technology |
Inhalable nanosensors with volatile reporters and uses thereof
|
US11835522B2
(en)
|
2019-01-17 |
2023-12-05 |
Massachusetts Institute Of Technology |
Sensors for detecting and imaging of cancer metastasis
|
US11253587B2
(en)
|
2020-03-30 |
2022-02-22 |
Variation Biotechnologies Inc. |
Vaccine compositions for the treatment of coronavirus
|
EP4326769A1
(de)
|
2021-04-20 |
2024-02-28 |
Institut Curie |
Zusammensetzungen und verfahren zur verwendung in der immuntherapie
|
EP4326321A1
(de)
|
2021-04-20 |
2024-02-28 |
Institut Curie |
Zusammensetzungen und verfahren zur verwendung in der immuntherapie
|